1.
Malataras P, Pallikarakis N. Spin-off use of adverse events data: why and how. The case of FDA’s MAUDE. GlobalCE [Internet]. 2018Oct.13 [cited 2021Apr.13];1(1):9-23. Available from: https://globalce.org/index.php/GlobalCE/article/view/32